XML 14 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Net Income Attributable to Inter Parfums, Inc. Common Shareholders
9 Months Ended
Sep. 30, 2019
Net Income Attributable To Inter Parfums Inc. Common Shareholders [Abstract]  
Net Income Attributable to Inter Parfums, Inc. Common Shareholders

8.

Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share ("basic EPS") is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution ("diluted EPS"), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

Schedule of earnings per share, basic and diluted                            
   Three months ended   Nine months ended 
  September 30,   September 30, 
(In thousands)  2019   2018   2019   2018 
Numerator:                
Net income attributable to Inter Parfums, Inc.  $20,848   $18,938   $52,059   $45,746 
Denominator:                    
Weighted average shares   31,452    31,326    31,444    31,297 
Effect of dilutive securities:                    
Stock options   224    261    237    205 
Denominator for diluted earnings per share   31,676    31,587    31,681    31,502 
                     
Earnings per share:                    
Net income attributable to Inter Parfums, Inc. common shareholders:                    
Basic  $0.66   $0.60   $1.66   $1.46 
Diluted   0.66    0.60    1.64    1.45 

 

Not included in the above computations are the effect of antidilutive potential common shares which consist of outstanding options to purchase 0.18 million shares of common stock for both the three and nine months ended September 30, 2019, as compared to .12 million shares of common stock for the nine months ended September 30, 2018. For the three months ended September 30, 2018 there were no antidilutive potential common shares.